Aptevo Therapeutics Files 2024 Proxy Statement

Ticker: APVO · Form: DEF 14A · Filed: Jul 15, 2024 · CIK: 1671584

Aptevo Therapeutics Inc. DEF 14A Filing Summary
FieldDetail
CompanyAptevo Therapeutics Inc. (APVO)
Form TypeDEF 14A
Filed DateJul 15, 2024
Risk Levellow
Pages16
Reading Time19 min
Key Dollar Amounts$0.001, $15,000, $0.515, $0.0001, $0.5149
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, governance, annual-meeting

Related Tickers: APVO

TL;DR

APVO proxy statement out for Aug 6 meeting - vote on board & auditors.

AI Summary

Aptevo Therapeutics Inc. filed a definitive proxy statement (DEF 14A) on July 15, 2024, for its annual meeting of stockholders scheduled for August 6, 2024. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of independent auditors.

Why It Matters

This filing provides shareholders with crucial information to make informed voting decisions on company leadership and strategic direction at the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine proxy filing, providing information to shareholders rather than announcing new material events.

Key Players & Entities

  • Aptevo Therapeutics Inc. (company) — Registrant
  • 20240715 (date) — Filing Date
  • 20240806 (date) — Meeting Date

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to provide shareholders with a proxy statement for the annual meeting of stockholders, outlining information necessary for them to vote on company matters.

When is the Aptevo Therapeutics Inc. annual meeting of stockholders scheduled?

The annual meeting of stockholders for Aptevo Therapeutics Inc. is scheduled for August 6, 2024.

Who is the filer of this proxy statement?

Aptevo Therapeutics Inc. is the registrant and the filer of this proxy statement.

What is the filing date of this document?

This document was filed on July 15, 2024.

What is the Standard Industrial Classification code for Aptevo Therapeutics Inc.?

The Standard Industrial Classification code for Aptevo Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 4,802 words · 19 min read · ~16 pages · Grade level 12.7 · Accepted 2024-07-15 08:19:35

Key Financial Figures

  • $0.001 — our outstanding common stock, par value $0.001 per share (Common Stock), issuable upon
  • $15,000 — g. We have agreed to pay Okapi a fee of $15,000. We will also reimburse Okapi for reaso
  • $0.515 — n Stock at a combined offering price of $0.515 per share and Common Warrants. Each sha
  • $0.0001 — of Common Stock at an exercise price of $0.0001 per share. Each Pre-Funded Warrant was
  • $0.5149 — priced at a combined offering price of $0.5149 per Pre-Funded Warrant and accompanying

Filing Documents

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 12 Householding of Proxy Materials 13 Other Matters 14 APPENDIX A A- 1 APTEVO THERAPEUTICS INC. 2401 4th Avenue, Suite 1050 Seattle, Washington 98121 PROXY STATEMENT FOR THE SPECIAL MEETING OF STOCKHOLDERS To be held on August 6, 2024 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING When is this Proxy Statement and accompanying proxy card (Proxy Card) first being mailed to stockholders? This Proxy Statement and Proxy Card are first being mailed on or about July 12 , 2024 to stockholders of record entitled to vote at the Special Meeting. How do I attend the Special Meeting? In order to facilitate stockholder participation and save costs, the meeting will be held virtually on August 6, 2024 at 10 a.m. Pacific Time. There will not be a physical meeting . We have worked to offer the same participation opportunities as if you attended the Special Meeting in person and hope the online format will allow more stockholders to participate by removing any barriers caused by travel requirements. You may attend the Special Meeting online, including voting and submitting questions, at www.virtualshareholdermeeting.com/APVO2024SM by entering the 16-digit control number included on your Proxy Card. You should ensure you have a strong Internet connection wherever you intend to participate in the Special Meeting. We encourage you to access the Special Meeting before it begins. Online check-in will begin at 9:30 a.m. Pacific Time on the date of the Special Meeting. Our virtual meeting provider, Broadridge, facilitates stockholders’ opportunity to ask questions before and during the meeting. The Special Meeting site will provide stockholders with information regarding (i) time guidelines for their questions, rules around what types of questions are allowed, and rules for how questions and comments will be recognized and disclosed to meeting participants; and (ii) proc

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.